RecruitingPhase 3NCT04965675
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Sponsor: H. Lundbeck A/S
Amherst, NY · Commack, NY · +20 more sites
Migraine clinical trials in Amherst, NY
12 recruiting migraine studies with a site in Amherst, NY.
RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Amherst, NY · Brooklyn, NY · Commack, NY · +110 more sites
RecruitingPhase 3NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Sponsor: Pfizer
Amherst, NY · The Bronx, NY · +54 more sites
RecruitingPhase 3NCT05164172
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Sponsor: H. Lundbeck A/S
Amherst, NY · Commack, NY · +18 more sites
RecruitingPhase 3NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Amherst, NY · +31 more sites
RecruitingPhase 3NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Amherst, NY · New York, NY · +40 more sites
RecruitingPhase 2NCT07616128
Study of EVO756 in Adults With Migraine
Sponsor: Evommune, Inc.
Amherst, NY · +32 more sites
RecruitingPhase 3NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sponsor: Pfizer
Amherst, NY · Commack, NY · Great Neck, NY · +166 more sites
RecruitingPhase 3NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sponsor: Pfizer
Amherst, NY · Commack, NY · New York, NY · +112 more sites
RecruitingNot applicableNCT05889624
Responding With Evidence and Access for Childhood Headaches
Sponsor: Children's Hospital Medical Center, Cincinnati
Amherst, NY · +14 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Amherst, NY · Mount Kisco, NY · New York, NY · +122 more sites
RecruitingPhase 3NCT07645924
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Amherst, NY · Brooklyn, NY · Commack, NY · +110 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.